000			01087cam a2200349 a 4500
001			17159619
003			BD-DhUL
005			20151012103337.0
008			120210s2012 ne a b 001 0 eng c
010			_a 2011294197
016	7		_a101575674 _2DNLM
020			_a9780123919113
035			_a(OCoLC)ocn772582481
040			_aNLM _beng _cNLM _dYDXCP _dDLC _dBD-DhUL
042			_apcc
050	0	0	_aR853.C55 _bB76 2012
060	0	0	_aQV 771 _bC64195 2012
082	0	0	_a615.50724 _223 _bBRC
100	1		_aBrody, Tom.
245	1	0	_aClinical trials : _bstudy design, endpoints and biomarkers, drug safety, FDA and ICH guidelines / _cTom Brody.
260			_aAmsterdam ; _aBoston : _bElsevier/AP, _c2012.
300			_axxxiii, 638 p. : _bill. ; _c24 cm.
365			_aUS$ _b83.95
504			_aIncludes bibliographical references and index.
650		0	_aClinical trials.
650		0	_aDrug approval.
650	1	2	_aClinical Trials as Topic.
650	2	2	_aClinical Trials Data Monitoring Committees.
650	2	2	_aDrug Approval.
650	2	2	_aResearch Design.
942			_2ddc _cBK
999			_c41681 _d41681